a person wearing a dark suit and bright orange tie standing indoors with a high-rise building visible through the window in the background

Dr. Wilson Chew

Chairman (Non-Executive)

Advises boards, business owners and senior management in formulating strategy and execution plans for capital markets initiatives.

We’ve Emerged Stronger

“Dr. Wilson Chew has been involved in many facets of Mooreast’s developments. With his careful guidance, we’ve emerged stronger despite the challenging pandemic period.”

ABOUT

Dr. Wilson Chew is the non-executive Chairman of J.P. Wilson. He has over 20 years of experience in Enterprise Growth Strategy. He has served more than 200 private clients, led over 140 strategy engagements, 12 public listings and 26 private transactions.

In his work with private clients, Dr. Chew journeys with business leaders to formulate strategy and execution plans to reach their growth ambitions. He firmly believes in an evidence-based approach, with firsthand experience having founded and sold two companies.

Dr. Chew was formerly a Partner in PwC’s strategy practice. He was one of the lead consultants in the national Scale-up Programme, which supports selected local companies (by the Singapore Government) with high-growth potential to scale and become leaders in their fields.

Dr. Chew’s research work on Enterprise Strategy is widely published in 4 books and multiple publications in academic journals and mainstream media. He is the course leader of The Strategy & Innovation Masterclass for Directors and a faculty member at the Singapore Institute of Directors. Dr. Chew serves as a visiting tutor/lecturer at Nanyang Technological University, University of Strathclyde (Glasgow) and Singapore Management University.

EXPERTISE

  • Growth strategy for capital markets initiatives
  • TRACK RECORD

  • 2023: Strategy Formulation – Singapore-based Global Logistics Service Provider (Revenue: S$120mn)
  • 2023: Management Planning & Succession Strategy – Global Petrochemical Trading Company (Revenue: S$110mn)
  • 2023: Corporate Repositioning Strategy – Mooring Solutions Specialist. Successfully listed on The Singapore Exchange (Revenue: S$28mn)
  • 2022: Internationalisation and Corporate Strategy Formulation – Singapore-based Global Specialty Chemical Blending Company. Successfully listed on the Tokyo Exchange (Revenue: S$300mn)
  • 2022: Business Re-Modelling – Regional Food Trading Company (Revenue: S$135mn)
  • 2022: Regional Market Expansion Strategy – Municipal & Industrial Cleaning Service Company (Revenue: S$135mn)
  • 2021: Regional Market Expansion Strategy – Food Flavour & Aroma Manufacturing Company (Revenue: S$90mn)
  • 2021: Regional Market Expansion & M&A Strategy – Listed APAC-based Payroll and HCM Company. Acquired by Global Payroll Company for AU$121mn
  • 2020: Corporate Strategy and Business Re-modelling – Infrastructure Construction and Engineering Company. Successfully listed on The Singapore Exchange (Revenue: S$228mn)
  • 2019: Corporate Strategy Review – Integrated Logistics Solutions Provider. Successfully listed on The Singapore Exchange (Revenue: S$202mn)
  • 2018: Corporate Strategy Review: Global Engineering and Science Company. Successfully listed on The Singapore Exchange (Revenue: S$155mn)
  • 2017: Regional Market Expansion Strategy – Real Estate Management Services Company, Successfully dual-listed on The Singapore Exchange and The Hong Kong Exchange (Revenue: S$112mn)
  • BOARD APPOINTMENTS

  • 2013-2022: Singapore Institute of Directors (registered professional society: non-profit)
  •      Chairman: Professional Development (2014 – 2019)
         Chairman: Regulatory Affairs & Accreditation (2019 – 2022)
         Board Director
  • 2012-2022: National Arthritis Foundation (registered Charity: Ministry of Health)
  •      Deputy Chairman (2018 – 2022)
         Board Director (2012 – 2018)
  • 2012-2014: Swee Hong Limited (publicly listed on Singapore Exchange)
  •      Chairman, Remuneration Committee
         Board Director

    PUBLISHED WORK

  • Differentiation – How to Win in a Disruptive Market (2017)
  • Killer Differentiators – 13 Strategies to Grow Your Brand (2008)
  • Transforming Your Business into a Brand – The 10 Rules of Branding (2007)
  • EDUCATION

  • 2024: Juris Doctor (Law (Hons)), Singapore University of Social Sciences
  • 2015: Post-Doctorate Readings on Corporate Board Leadership, Harvard Business School ​
  • 2014: Doctor of Business Administration (Economics and Finance), University of South Australia
  • 2007: Master of Business Administration, University of Strathclyde
  • Your Growth Partners

    Dr. Tim Andrews

    Partner (Thailand)

    Aloysius Arlando

    Partner (Singapore)

    Dr. Wilson Chew

    Chairman (Non-Executive)

    JK Low

    Partner (Singapore)

    Arindam Mukherjee

    Partner (Thailand)

    Jaslene Pang

    Managing Director

    Ahmad Raji

    Partner (Malaysia)

    Adam Said

    Partner (Malaysia)

    Gerald Tan

    Partner (Singapore)

    Arlene Wherrett

    Partner (Australia)

    You cannot copy content of this page